Publication: Mast cells are an essential hematopoietic component for polyp development
No Thumbnail Available
Open/View Files
Date
2007
Published Version
Journal Title
Journal ISSN
Volume Title
Publisher
National Academy of Sciences
The Harvard community has made this article openly available. Please share how this access benefits you.
Citation
Gounaris, E., S. E. Erdman, C. Restaino, M. F. Gurish, D. S. Friend, F. Gounari, D. M. Lee, et al. 2007. “Mast Cells Are an Essential Hematopoietic Component for Polyp Development.” Proceedings of the National Academy of Sciences 104 (50): 19977–82. https://doi.org/10.1073/pnas.0704620104.
Research Data
Abstract
It is generally agreed that most colon cancers develop from adenomatous polyps, and it is this fact on which screening strategies are based. Although there is overwhelming evidence to link intrinsic genetic lesions with the formation of these preneoplastic lesions, recent data suggest that the tumor stromal environment also plays an essential role in this disease. In particular, it has been suggested that CD34(+) immature myeloid precursor cells are required for tumor development and invasion. Here we have used mice conditional for the stabilization of beta-catenin or defective for the adenomatous polyposis coli (APC) gene to reinvestigated the identity and importance of tumor-infiltrating hematopoietic cells in polyposis. We show that, from the onset, polyps are infiltrated with proinflammatory mast cells (MC) and their precursors. Depletion of MC either pharmacologically or through the generation of chimeric mice with genetic lesions in MC development leads to a profound remission of existing polyps. Our data suggest that MC are an essential hematopoietic component for preneoplastic polyp development and are a novel target for therapeutic intervention.
Description
Other Available Sources
Keywords
Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service